D.E. Shaw & Co
ACHC icon

D.E. Shaw & Co’s Acadia Healthcare ACHC Stock Holding History

D.E. Shaw & Co’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,700
Closed -$320K – 4837
2026
Q1 		$320K Sell
13,700
-14,800
-52% -$268K ﹤0.01% 4051
2025
Q4 		$404K Sell
28,500
-4,600
-14% -$87K ﹤0.01% 4021
2025
Q3 		$820K Buy
+33,100
New +$738K ﹤0.01% 3581
2014
Q1 		– Sell
-15,600
Closed -$738K – 4230
2013
Q4 		$738K Sell
15,600
-20,000
-56% -$869K ﹤0.01% 3421
2013
Q3 		$1.4M Buy
35,600
+15,600
+78% +$579K ﹤0.01% 2740
2013
Q2 		$661K Buy
+20,000
New +$649K ﹤0.01% 3034

Other funds holding ACHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

D.E. Shaw & Co's ACHC Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Acadia Healthcare (ACHC) stake by 42% in Q2 2026, selling an estimated $1.01M and leaving 55,336 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3369.

D.E. Shaw & Co first reported a position in ACHC in Q2 2014 and has held it in 26 quarters since. The position peaked at $54.4M in Q3 2025. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • D.E. Shaw & Co held 55,336 shares of Acadia Healthcare worth $1.63M as of Q2 2026.
  • D.E. Shaw & Co sold 39,385 Acadia Healthcare shares in Q2 2026, an estimated $1.01M.
  • Acadia Healthcare made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3369 holding.
  • D.E. Shaw & Co first reported a position in Acadia Healthcare in Q2 2014 and has held it in 26 quarters since.
  • D.E. Shaw & Co's Acadia Healthcare position peaked at $54.4M in Q3 2025.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.